Perrigo Company PLC (NYSE:PRGO)
| 43.76 BATS BZX Real-Time Price As of 9:45am ET |  +0.05 / +0.11%Today’s Change | 40.01 Today|||52-Week Range 63.86 | -2.15% Year-to-Date |
Latest PRGO News | Press Releases
No recent news for Perrigo Company PLC.
Today’s Trading
| Previous close | 43.71 |
| Today’s open | 45.94 |
| Day’s range | 43.50 - 43.76 |
| Volume | 23,283 |
| Average volume (3 months) | 955,785 |
| Market cap | $6.0B |
Data as of 9:45am ET, 01/19/2021
Growth & Valuation
| Earnings growth (last year) | +13.01% |
| Earnings growth (this year) | +1.96% |
| Earnings growth (next 5 years) | +2.00% |
| Revenue growth (last year) | +2.24% |
| P/E ratio | NM |
| Price/Sales | 1.46 |
| Price/Book | 1.03 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| FOLDAmicus Therapeutics ... | -0.12 | -0.55% |
| TPTXTurning Point Therap... | +4.16 | +3.16% |
| GLPGGalapagos NV | +5.94 | +5.94% |
| SAGESAGE Therapeutics In... | +0.99 | +1.08% |
Data as of 9:47am ET, 01/19/2021
Financials
| Next reporting date | March 4, 2021 |
| EPS forecast (this quarter) | $1.01 |
| Annual revenue (last year) | $4.8B |
| Annual profit (last year) | $146.1M |
| Net profit margin | 3.02% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Dublin, Dublin |
Forecasts
